Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, has announced it will release its 2024 second quarter financial results on Monday, August 12, 2024 after U.S. market close. The company will host a conference call and webcast at 4:30 p.m. EST to discuss the results and corporate developments.
Interested parties can access the live call by dialing 800-715-9871 (US and Canada) or 1-646-307-1963 (International) with the participant pass code 7734844. A live and replay webcast will be available on the investor relations section of Stereotaxis' website. A phone replay will be accessible for one month following the call.
Stereotaxis, listed on the NYSE, is a global leader in innovative surgical robotics, focusing on minimally invasive endovascular interventions. Their technology has been used to treat over 100,000 patients worldwide.
Stereotaxis (NYSE: STXS), un pioniere nella robotica chirurgica per interventi endovascolari minimamente invasivi, ha annunciato che pubblicherà i suoi risultati finanziari del secondo trimestre 2024 lunedì 12 agosto 2024 dopo la chiusura del mercato statunitense. L'azienda terrà una conference call e un webcast alle 4:30 p.m. EST per discutere i risultati e gli sviluppi aziendali.
Le parti interessate possono accedere alla chiamata dal vivo componendo il numero 800-715-9871 (US e Canada) o 1-646-307-1963 (Internazionale) con il codice partecipante 7734844. Un webcast dal vivo e una registrazione saranno disponibili nella sezione relazioni con gli investitori del sito web di Stereotaxis. Una registrazione telefonica sarà accessibile per un mese dopo la chiamata.
Stereotaxis, quotata in borsa, è un leader globale nella robotica chirurgica innovativa, focalizzandosi su interventi endovascolari minimamente invasivi. La loro tecnologia è stata utilizzata per trattare oltre 100.000 pazienti in tutto il mondo.
Stereotaxis (NYSE: STXS), un pionero en robótica quirúrgica para intervenciones endovasculares mínimamente invasivas, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el lunes 12 de agosto de 2024 después del cierre del mercado estadounidense. La empresa realizará una conferencia telefónica y una transmisión en vivo a las 4:30 p.m. EST para discutir los resultados y los desarrollos corporativos.
Las partes interesadas pueden acceder a la llamada en vivo marcando el 800-715-9871 (EE. UU. y Canadá) o el 1-646-307-1963 (Internacional) con el código de participante 7734844. Una transmisión en vivo y una repetición estarán disponibles en la sección de relaciones con los inversores en el sitio web de Stereotaxis. Se accederá a una repetición telefónica durante un mes después de la llamada.
Stereotaxis, que cotiza en la bolsa, es un líder global en robótica quirúrgica innovadora, enfocándose en intervenciones endovasculares mínimamente invasivas. Su tecnología ha sido utilizada para tratar a más de 100,000 pacientes en todo el mundo.
스테레오탁시스(Stereotaxis, NYSE: STXS)는 최소 침습 혈관 내 시술을 위한 수술 로봇 분야의 선두주자로, 2024년 2분기 재무 실적을 2024년 8월 12일 월요일 미국 시장 마감 후 발표할 예정이라고 밝혔습니다. 이 회사는 오후 4시 30분 EST에 결과와 기업 발전에 대해 논의하는 컨퍼런스 콜 및 웹캐스트를 개최할 것입니다.
관심 있는 분들은 800-715-9871(미국 및 캐나다) 또는 1-646-307-1963(국제)로 전화하여 참여자 비밀번호 7734844를 입력하면 실시간 통화에 참여할 수 있습니다. 스테레오탁시스 웹사이트의 투자자 관계 섹션에서 실시간 및 재생 웹캐스트를 이용할 수 있으며, 통화 후 한 달 동안 전화 재생 서비스를 이용할 수 있습니다.
스테레오탁시스는 NYSE에 상장된 기업으로, 혁신적인 수술 로봇 분야에서 세계적인 리더로서 최소 침습 혈관 내 시술에 중점을 두고 있습니다. 이들의 기술은 전 세계 100,000명 이상의 환자를 치료하는 데 사용되었습니다.
Stereotaxis (NYSE: STXS), un pionnier de la robotique chirurgicale pour les interventions endovasculaires peu invasives, a annoncé qu'il publiera ses résultats financiers du deuxième trimestre 2024 le lundi 12 août 2024 après la fermeture du marché américain. L'entreprise organisera une conférence téléphonique et un webinaire à 16h30 EST pour discuter des résultats et des développements de l'entreprise.
Les parties intéressées peuvent accéder à la conférence en direct en composant le 800-715-9871 (États-Unis et Canada) ou le 1-646-307-1963 (International) avec le code de participation 7734844. Un webinaire en direct et une rediffusion seront disponibles dans la section des relations avec les investisseurs du site Web de Stereotaxis. Une rediffusion téléphonique sera accessible pendant un mois après l’appel.
Stereotaxis, coté en bourse, est un leader mondial dans le domaine de la robotique chirurgicale innovante, se concentrant sur les interventions endovasculaires peu invasives. Leur technologie a été utilisée pour traiter plus de 100 000 patients dans le monde entier.
Stereotaxis (NYSE: STXS), ein Pionier der chirurgischen Robotik für minimal-invasive endovaskuläre Eingriffe, hat angekündigt, dass es seine Finanzergebnisse für das zweite Quartal 2024 am Montag, dem 12. August 2024 nach dem US-Markt schließen wird. Das Unternehmen wird um 16:30 Uhr EST eine Telefonkonferenz und einen Webcast durchführen, um die Ergebnisse und Unternehmensentwicklungen zu besprechen.
Interessierte Parteien können die Live-Konferenz unter 800-715-9871 (USA und Kanada) oder 1-646-307-1963 (International) mit dem Teilnehmerpasswort 7734844 erreichen. Ein Live-Webcast und eine Wiederholung werden im Bereich Investor Relations auf der Website von Stereotaxis verfügbar sein. Eine telefonische Wiederholung wird einen Monat lang nach der Konferenz verfügbar sein.
Stereotaxis, das an der NYSE gelistet ist, ist ein globaler Marktführer in innovativer chirurgischer Robotik und konzentriert sich auf minimal-invasive endovaskuläre Eingriffe. Ihre Technologie wurde weltweit zur Behandlung von über 100.000 Patienten eingesetzt.
- Stereotaxis is a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention
- The company's technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere
- None.
ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2024 second quarter on Monday, August 12, 2024 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. EST that day to discuss the Company’s results and corporate developments.
| What: | Stereotaxis second quarter 2024 financial results conference call |
| When: | Monday, August 12, 2024, at 4:30 p.m. ET (1:30 p.m. PT) |
| Dial In Number: | To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 7734844. |
| Webcast: | To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/. |
| Call Replay: | A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here. |
About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.
Investor Contacts:
David L. Fischel
Chairman and Chief Executive Officer
Kimberly Peery
Chief Financial Officer
314-678-6100
Investors@Stereotaxis.com
FAQ
When will Stereotaxis (STXS) release its Q2 2024 financial results?
What time is the Stereotaxis (STXS) Q2 2024 earnings conference call?
How can I access the Stereotaxis (STXS) Q2 2024 earnings call?
Where can I find the replay of Stereotaxis (STXS) Q2 2024 earnings call?
